Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BLM | P54132 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.46 |
| ▸ | KDM4A | O75164 | 1/20 | 0.46 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.46 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.45 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.44 |
| ▸ | BHMT | Q93088 | 1/20 | 0.43 |
| ▸ | CACNA2D1 | P54289 | 2/20 | 0.38 |
| ▸ | CACNB3 | P54284 | 1/20 | 0.38 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.38 |
| ▸ | PGR | P06401 | 1/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.38 |
| ▸ | HTR2B | P41595 | 1/20 | 0.38 |
| ▸ | CACNA2D2 | Q9NY47 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5743247 | 1.00 | BLM (0.52) | BLMLMNAKDM4CKDM4APHF8 | |
| SCHEMBL8626585 | 0.93 | BLM (0.59) | BLMLMNAKDM4CKDM4APHF8 | |
| SCHEMBL9858195 | 0.93 | BLM (0.59) | BLMLMNAKDM4CKDM4APHF8 | |
| SCHEMBL1683970 | 0.93 | BLM (0.59) | BLMLMNAKDM4CKDM4APHF8 | |
| SCHEMBL29991721 | 0.93 | GPR84 (0.50) | BLMGPR84ACE2BHMT | |
| Phytanic Acid SCHEMBL5270871 | 0.91 | BLM (0.63) | BLMLMNAKDM4CKDM4APHF8 | |
| SCHEMBL2353062 | 0.91 | BLM (0.63) | BLMLMNAKDM4CKDM4APHF8 | |
| Phytanic Acid SCHEMBL61162 | 0.91 | BLM (0.63) | BLMLMNAKDM4CKDM4APHF8 | |
| SCHEMBL2356998 | 0.91 | BLM (0.63) | BLMLMNAKDM4CKDM4APHF8 | |
| Phytanic Acid SCHEMBL7889 | 0.91 | BLM (0.63) | BLMLMNAKDM4CKDM4APHF8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100104625-A1 | BIODEGRADABLE COMPOSITIONS AND MATERIALS | CORNELL UNIVERSITY (US) | 2010-04-29 | — | — | US | disclosed |
| WO-2008101173-A2 | BIODEGRADABLE COMPOSITIONS AND MATERIALS | CORNELL UNIVERSITY (US) | 2008-08-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100104625-A1 | BIODEGRADABLE COMPOSITIONS AND MATERIALS | F12, CMA1, TREH | BLM 411/4885LMNA 1017/4885KDM4C 2770/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.